Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dactinomycin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 199 for your search:
Start Over
Phase II/III Pilot Combination Chemotherapy and Radiotherapy for Previously Untreated Childhood ALL with Poor Prognosis
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
Phase II/III Study of L-PAM or IPP/Mesna, Followed by Conventional Chemotherapy with VCR/CTX/ADR plus CTX/VCR/ACT-D/ADR, Surgery, and Radiotherapy, for Stage IIB/IIC/IIIA/IIIB Rhabdomyosarcoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-RMS-V, NCI-T86-0152D, T86-0152
Phase II-III Chemotherapy with ACT-D/5-FU/CTX and/or Radiotherapy for Malignant Tumors of the Ovarian Stroma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-14
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: 9444, COG-Q9402, NWTS-Q9402, CCG-4942, POG-9444, INT-0152, NWTS-5/R, CDR0000063900, Q9402, NCT00002610
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 16
Sponsor: NCI, Other
Protocol IDs: 9440, COG-Q9401, NWTS-Q9401, CCG-4941, POG-9440, INT-0150, NWTS-5, CDR0000063901, Q9401, NCT00002611
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-015, P30CA008748, MSKCC-96015A1, NCI-V96-0881, NCT00002766
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: D9602, COG-D9602, CCG-D9602, POG-D9602, IRS-D9602, CDR0000065542, NCT00002995
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0174, NCI-2011-02026, ECOG-G174, CDR0000066809, U10CA027469, GOG-174, NCT00003702
Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
Phase: Phase III
Type: Treatment
Status: Closed
Age: 0.5 to 17
Sponsor: Other
Protocol IDs: CDR0000066948, SIOP-93-01, EU-98064, NCT00003804
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: D9803, NCI-2012-02302, IRS-D9803, COG-D9803, POG-D9803, CDR0000067157, CCG-D9803, U10CA098543, NCT00003958
Phase III Chemotherapy with CTX/ADR/MTX with or without Alternating ACT-D/DTIC/VCR for Metastatic Sarcomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: SEG-356
Phase III Chemotherapy with VBL/BLEO vs ACT-D/VCR/BLEO for Metastasized Testicular Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7303
Phase III Chemotherapy with ADR/DTIC and CTX or ACT-D for Advanced Soft Tissue Sarcomas (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7613, MDAR-145
Phase III Chemotherapy with BHD (BCNU/HU/DTIC) and Levamisole Immunotherapy vs DTIC/ACT-D for Disseminated Melanoma (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7727/28
Phase III Combination Chemotherapy plus Radiotherapy and Surgery for Metastatic Ewing's Sarcoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-8095, CCG-785, MDAR-431
Phase III Chemotherapy with VAC (VCR/ACT-D/CTX) vs VADRC (VCR/ADR/CTX) plus Radiotherapy and/or Surgery for Group I/II/III/IV Rhabdomyosarcoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-7898, CCG-681, IRS-II
Phase III Randomized Evaluation of Various Combination Chemotherapies or C. parvum Immunotherapy for Epithelial Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-026-064, RPMI-7603
Phase III Chemotherapy with VBP (VBL/BLEO/CACP) and VAC (VCR/ACT-D/CTX) for Stage III/IV or Recurrent Malignant Germ Cell Tumors of the Ovary
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor: NCI
Protocol IDs: GOG-45, GOG-7864
Phase III VP-16/CACP vs VAB-6 (VBL/ACT-D/CTX/BLEO/CACP) for Advanced, Stage II/III Good-Prognosis Testicular Germ Cell Tumors
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-82132R, NCI-C82-1434
Phase III Intensive Postoperative Adjuvant Combination Chemotherapy in Nonmetastatic Osteogenic Sarcoma Localized in an Extremity (Summary Last Modified 04/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 30
Sponsor: NCI
Protocol IDs: DFCI-81093, NCI-82-C-67, POG-8107, NCI-POB-8202, NCI-T83-0987D, T83-0987
Start Over